Did Corteva's Q1 2026 results beat or miss expectations, and what drove the strength?

The release does not include consensus estimates, so a beat or miss cannot be determined from this filing. Results showed strong year-over-year growth. Seed drove most of the improvement, with volume up 6%, price/mix up 3%, and favorable currency, while Operating EBITDA grew 21% on cost and productivity gains. Part of the Seed sales strength reflects timing shifts in North American deliveries.

Is Corteva reaffirming or changing its 2026 outlook?

Corteva reaffirmed its full-year 2026 guidance, including Operating EBITDA of $4.0-$4.2 billion and Operating EPS of $3.45-$3.70 per share. Both midpoints imply roughly 7% growth. Management said the net impact of geopolitical and trade developments should be manageable within the current guidance.

What are the key risks in the quarter's GAAP results?

GAAP results include $177 million of pre-tax significant items, mainly an $85 million Crop Protection loyalty program litigation settlement and $92 million of restructuring charges. There were also $52 million of separation costs and $67 million of pre-tax exchange losses. Operating cash flow was negative $2.9 billion, reflecting seasonal receivable and deferred revenue movements. Cash fell to $1.96 billion, and short-term borrowings rose to $1.67 billion from $0.89 billion at year-end.

What is the status of the separation into two companies?

Corteva remains on track to complete the separation in 2H 2026. Key steps are complete or underway: the initial Form 10 has been filed, Luke Kissam was named CEO of New Corteva, and the future seed company was named Vylor. Still ahead are the public Form 10 filing in late Q2, credit agency reviews, approval of final capital structures, board appointments, and a September 15, 2026 Investor Day. One-time separation costs are estimated at about $350 million, and net dis-synergies at about $100 million, with $50 million in 2026 guidance.

How is Corteva managing its capital allocation during the separation?

Corteva plans to repurchase about $500 million of shares in 1H 2026 and made $250 million of repurchases in Q1. The Board approved a discretionary pension contribution of about $1.5 billion pre-tax, to be made by July 31, 2026. The company expects both companies to hold strong balance sheets and investment grade credit ratings after separation.

CTVA 8-K: Earnings & Results

01—Abstract

Summary

Summary of the 8-K filed May 5, 2026. Cited figures are marked; the original filing is the authoritative source.

Corteva (CTVA) reported first-quarter 2026 results that beat on growth and profitability, with GAAP net sales up 11% to $4.90 billion^a (7% organic) and GAAP EPS from continuing operations of $1.07.

Operating EBITDA rose 21% to $1.44 billion^b and Operating EPS rose 33% to $1.50. Seed was the main driver, with net sales up 12% (9% organic) and segment operating EBITDA up 23%, while Crop Protection net sales rose 10% (4% organic) and segment operating EBITDA rose 15%. Price/mix was positive in Seed (+3%) but negative in Crop Protection (-2%, driven by Latin America and APAC competition), while volume grew 6% in both segments.

Management reaffirmed full-year 2026 guidance of Operating EBITDA of $4.0^c-$4.2 billion and Operating EPS of $3.45-$3.70, and reiterated plans to repurchase about $500 million of shares in the first half of 2026. The quarter's GAAP results also absorbed $177 million of pre-tax significant items, including an $85 million litigation settlement tied to the Crop Protection loyalty program MDL and $92 million of restructuring charges, plus $52 million of separation costs. Cash flow from operations was negative $2.9 billion, a seasonal working-capital build driven by a $2.8 billion increase in receivables, while cash fell to $1.96 billion from $4.52 billion at year-end.

The separation into two companies remains on track for the second half of 2026. Vylor will be the future seed and genetics company, with Luke Kissam named CEO of New Corteva.

The one-time separation costs are expected to be about $350 million^d, net dis-synergies about $100 million, and the company plans a discretionary pension contribution of about $1.5 billion by July 31, 2026. Investors should watch the Form 10 filing, credit agency reviews, and the September 15, 2026 Investor Day for further detail on capital structures.

02—Key points

Key Highlights

Net sales rose 11% to $4.905 billion in Q1 2026 (7% organic), with Seed up 12% and Crop Protection up 10%.
Operating EBITDA increased 21% to $1.438 billion; Operating EPS rose 33% to $1.50 versus $1.13 a year earlier.
GAAP EPS from continuing operations was $1.07, versus $0.97 in Q1 2025, after $177 million of pre-tax significant items and $52 million of separation costs.
Full-year 2026 guidance was reaffirmed: Operating EBITDA of $4.0-$4.2 billion and Operating EPS of $3.45-$3.70.
Seed segment operating EBITDA rose 23% to $1.034 billion, with margin up about 310 basis points on volume, price execution, and productivity gains.
Crop Protection price declined 2%, driven by competitive pressure in Latin America and APAC, although volume grew 6%.
Separation remains on track for 2H 2026, with a ~$350 million one-time cost estimate and a ~$1.5 billion discretionary pension contribution due by July 31, 2026.

03—Questions

Frequently Asked Questions

Did Corteva's Q1 2026 results beat or miss expectations, and what drove the strength?
The release does not include consensus estimates, so a beat or miss cannot be determined from this filing. Results showed strong year-over-year growth. Seed drove most of the improvement, with volume up 6%, price/mix up 3%, and favorable currency, while Operating EBITDA grew 21% on cost and productivity gains. Part of the Seed sales strength reflects timing shifts in North American deliveries.
Is Corteva reaffirming or changing its 2026 outlook?
Corteva reaffirmed its full-year 2026 guidance, including Operating EBITDA of $4.0-$4.2 billion and Operating EPS of $3.45-$3.70 per share. Both midpoints imply roughly 7% growth. Management said the net impact of geopolitical and trade developments should be manageable within the current guidance.
What are the key risks in the quarter's GAAP results?
GAAP results include $177 million of pre-tax significant items, mainly an $85 million Crop Protection loyalty program litigation settlement and $92 million of restructuring charges. There were also $52 million of separation costs and $67 million of pre-tax exchange losses. Operating cash flow was negative $2.9 billion, reflecting seasonal receivable and deferred revenue movements. Cash fell to $1.96 billion, and short-term borrowings rose to $1.67 billion from $0.89 billion at year-end.
What is the status of the separation into two companies?
Corteva remains on track to complete the separation in 2H 2026. Key steps are complete or underway: the initial Form 10 has been filed, Luke Kissam was named CEO of New Corteva, and the future seed company was named Vylor. Still ahead are the public Form 10 filing in late Q2, credit agency reviews, approval of final capital structures, board appointments, and a September 15, 2026 Investor Day. One-time separation costs are estimated at about $350 million, and net dis-synergies at about $100 million, with $50 million in 2026 guidance.
How is Corteva managing its capital allocation during the separation?
Corteva plans to repurchase about $500 million of shares in 1H 2026 and made $250 million of repurchases in Q1. The Board approved a discretionary pension contribution of about $1.5 billion pre-tax, to be made by July 31, 2026. The company expects both companies to hold strong balance sheets and investment grade credit ratings after separation.

04—Continue

← View all 8-K filings